Abstract:The metalloprotease ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats member 13) prevents microvascular thrombosis by cleaving von Willebrand factor (VWF) within platelet-rich thrombi, and cleavage depends on allosteric activation of ADAMTS13 by the substrate VWF. Human ADAMTS13 has a short propeptide, metalloprotease (M), disintegrin-like (D), thrombospondin-1 (T), Cys-rich (C), and spacer (S) domains (proximal domains), followed by 7 T and 2 CUB (complement components C1r and C1s, sea urchin protein Uegf, and bone morphogenetic protein-1) domains (distal domains). Distal domains inhibit the catalytic proximal domains; binding of distal T8-CUB domains to the VWF D4 domain relieves autoinhibition and promotes cleavage of the nearby VWF A2 domain. However, the role of specific ADAMTS13 distal domains in this allosteric mechanism is not established. Assays of plasma ADAMTS13 from 20 placental mammals, birds, and amphibians show that allosteric regulation is broadly conserved, and phylogenetic analysis of 264 vertebrates shows the long propeptide, T3, T4, T6, and T6a domains have been deleted several times in placental mammals, birds, and fish. Notably, pigeon ADAMTS13 has only 3 distal T domains but was activated normally by human VWF D4 and cleaved VWF multimers, preferentially under fluid shear stress. Human ADAMTS13 constructed to resemble pigeon ADAMTS13 retained normal allosteric regulation and shear-dependent cleavage of VWF. Thus, the T3-T6 domains of human ADAMTS13 are dispensable. Conversely, deletion of T7 or T8 abolished allosteric activation. For most species, some sequence changes in the VWF substrate can markedly increase the rate of cleavage, suggesting that ADAMTS13 and VWF have not evolved to be optimal enzyme-substrate pairs. These properties may reflect evolutionary pressure to balance the risk for VWF-dependent bleeding and thrombosis.

The Research of A Disintegrin-like and Metalloproteinase with Thrombospondin Type 1 Motifs

Basic researches and clinical significance of ADAMTS-1

Advance of ADAMTS Proteinases

Research advance in the function of a disintegin and metalloprotease 10

Role of ADAM and ADAMTS proteases in pathological tissue remodeling

Advances of research on ADAM and tumor target therapy

Pathological function of ADAMTS proteinases

Identification of a Crucial Tryptophan Residue in ADAMTS13 Required for Its Secretion and Enzymatic Activity.

Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics

[Biological Function of CysR Domain of ADAMTS13].

[Research on the C-terminal Domain of ADAMTS13 Regulates Its Cleaving Activity].

A Folded ADAMTS13 Conformation Identified by Small-Angle X-Ray Scattering Can Account for Allosteric Regulation by Distal Thrombospondin-1 and CUB Domains

Family of ADAMs and gastric and colorectal cancer

Residues R1075, D1090, R1095, and C1130 Are Critical in ADAMTS13 TSP8-Spacer Interaction Predicted by Molecular Dynamics Simulation

ADAMTS-12 Associates with and Degrades Cartilage Oligomeric Matrix Protein

Phylogenetic and Functional Analysis of ADAMTS13 Identifies Highly Conserved Domains Essential for Allosteric Regulation.

AFM Imaging Reveals Multiple Conformational States of ADAMTS13.

Purification and Functional Characterization of Two Thrombosis-Related Molecules: Von Willebrand Factor and ADAMTS-13

[Stable Expression and Characterization of the Von Willebrand Factor Cleaving Protease].

Thrombospondin-1 and ADAMTS13 Competitively Bind to VWF A2 and A3 Domains in Vitro.

The Function and Roles of ADAMTS-7 in Inflammatory Diseases